MOLINA HEALTHCARE, INC. (MOH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20B 40B 60B Q3 '16: 17.1B Q4 '16: 17.8B Q1 '17: 18.3B Q2 '17: 19B Q3 '17: 19.5B Q4 '17: 19.9B Q1 '18: 19.6B Q2 '18: 19.5B Q3 '18: 19.2B Q4 '18: 18.9B Q1 '19: 18.4B Q2 '19: 17.7B Q3 '19: 17.2B Q4 '19: 16.8B Q1 '20: 17.3B Q2 '20: 17.7B Q3 '20: 18.5B Q4 '20: 19.4B Q1 '21: 21.4B Q2 '21: 23.6B Q3 '21: 25.6B Q4 '21: 27.8B Q1 '22: 29B Q2 '22: 30.3B Q3 '22: 31.2B Q4 '22: 32B Q1 '23: 32.4B Q2 '23: 32.6B Q3 '23: 33.2B Q4 '23: 34.1B Q1 '24: 35.9B Q2 '24: 37.4B Q3 '24: 39.2B Q4 '24: 40.6B Q1 '25: 41.9B Q2 '25: 43.4B Q3 '25: 44.5B Q4 '25: 45.4B Q1 '26: 45.1B Q2 '26: 44.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 900M 1.8B 2.7B Q4 '15: 1.5B Q1 '16: 1.6B Q2 '16: 1.7B Q3 '16: 1.7B Q4 '16: 1.7B Q1 '17: 1.8B Q2 '17: 1.6B Q3 '17: 1.7B Q4 '17: 1.8B Q1 '18: 1.9B Q2 '18: 2.3B Q3 '18: 2.3B Q4 '18: 2.5B Q1 '19: 2.5B Q2 '19: 2.4B Q3 '19: 2.4B Q4 '19: 2.3B Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income TTM

-600M 0 600M 1.2B 1.8B Q4 '15: 387M Q1 '16: 394M Q2 '16: 383M Q3 '16: 388M Q4 '16: 306M Q1 '17: 299M Q2 '17: -93M Q3 '17: -292M Q4 '17: -555M Q1 '18: -415M Q2 '18: 214M Q3 '18: 590M Q4 '18: 1.1B Q1 '19: 1.2B Q2 '19: 1.1B Q3 '19: 1.1B Q4 '19: 1B Q1 '20: 1B Q2 '20: 1.2B Q3 '20: 1.2B Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 988M Q3 '21: 920M Q4 '21: 1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.3B Q4 '22: 1.2B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.4B Q4 '23: 1.6B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.6B Q4 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.7B Q3 '25: 1.3B Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Net Income TTM

-1B -500M 0 500M 1B 1.5B Q4 '15: 143M Q1 '16: 139M Q2 '16: 133M Q3 '16: 129M Q4 '16: 52M Q1 '17: 105M Q2 '17: -158M Q3 '17: -297M Q4 '17: -512M Q1 '18: -482M Q2 '18: -50M Q3 '18: 244M Q4 '18: 707M Q1 '19: 798M Q2 '19: 792M Q3 '19: 770M Q4 '19: 737M Q1 '20: 717M Q2 '20: 797M Q3 '20: 807M Q4 '20: 673M Q1 '21: 723M Q2 '21: 632M Q3 '21: 590M Q4 '21: 659M Q1 '22: 689M Q2 '22: 752M Q3 '22: 839M Q4 '22: 792M Q1 '23: 855M Q2 '23: 916M Q3 '23: 931M Q4 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.1B Q3 '25: 883M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Cost of Revenue TTM

0 15B 30B 45B Q4 '19: 13.9B Q1 '20: 14.2B Q2 '20: 14.4B Q3 '20: 15B Q4 '20: 15.8B Q1 '21: 17.6B Q2 '21: 19.8B Q3 '21: 21.8B Q4 '21: 23.7B Q1 '22: 24.8B Q2 '22: 25.8B Q3 '22: 26.5B Q4 '22: 27.2B Q1 '23: 27.5B Q2 '23: 27.6B Q3 '23: 28.2B Q4 '23: 28.7B Q1 '24: 30.2B Q2 '24: 31.5B Q3 '24: 32.9B Q4 '24: 34.4B Q1 '25: 35.5B Q2 '25: 37B Q3 '25: 38.4B Q4 '25: 39.5B Q1 '26: 39.3B Q2 '26: 38.9B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow TTM

-1B 0 1B 2B 3B Q3 '14: 919.5M Q4 '14: 1.1B Q1 '15: 1.4B Q2 '15: 1.5B Q3 '15: 1.1B Q4 '15: 1.1B Q1 '16: 710M Q2 '16: 755M Q3 '16: 852M Q4 '16: 673M Q1 '17: 1.3B Q2 '17: 1.1B Q3 '17: 997M Q4 '17: 804M Q1 '18: 479M Q2 '18: 446M Q3 '18: -344M Q4 '18: -314M Q1 '19: -459M Q2 '19: -472M Q3 '19: 275M Q4 '19: 434M Q1 '20: 328M Q2 '20: 1B Q3 '20: 635M Q4 '20: 1.9B Q1 '21: 2.3B Q2 '21: 2.2B Q3 '21: 2.8B Q4 '21: 2.1B Q1 '22: 1.9B Q2 '22: 1.8B Q3 '22: 1.6B Q4 '24: 644M Q1 '25: 620M Q2 '25: 537M Q3 '25: -461M Q4 '25: -535M Q1 '26: 357M Q2 '26: 365M Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '25 Q2 '26

Free Cash Flow TTM

-1B 0 1B 2B 3B Q4 '16: 497M Q1 '17: 1.1B Q2 '17: 933M Q3 '17: 879M Q4 '17: 718M Q1 '18: 415M Q2 '18: 406M Q3 '18: -369M Q4 '18: -344M Q1 '19: -491M Q2 '19: -508M Q3 '19: 239M Q4 '19: 377M Q1 '20: 256M Q2 '20: 953M Q3 '20: 544M Q4 '20: 1.8B Q1 '21: 2.3B Q2 '21: 2.1B Q3 '21: 2.8B Q4 '21: 2B Q1 '22: 1.8B Q2 '22: 1.7B Q3 '22: 1.5B Q4 '24: 544M Q1 '25: 525M Q2 '25: 427M Q3 '25: -574M Q4 '25: -636M Q1 '26: 251M Q2 '26: 271M Q2 '17 Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '13: 46.5M Q3 '13: 47.1M Q1 '14: 47.5M Q2 '14: 48M Q3 '14: 48.6M Q1 '15: 50M Q2 '15: 54M Q3 '15: 60M Q1 '16: 57M Q2 '16: 55M Q3 '16: 56M Q1 '17: 56M Q2 '17: 56M Q3 '17: 56.5M Q1 '18: 65.2M Q2 '18: 66.7M Q3 '18: 67.9M Q1 '19: 66.2M Q2 '19: 64M Q3 '19: 63.6M Q1 '20: 61M Q2 '20: 59.4M Q3 '20: 59.6M Q1 '21: 58.6M Q2 '21: 58.4M Q3 '21: 58.5M Q1 '22: 58.7M Q2 '22: 58.4M Q3 '22: 58.3M Q1 '23: 58M Q2 '23: 57.9M Q3 '23: 58.1M Q1 '24: 58.3M Q2 '24: 58.2M Q3 '24: 57.7M Q1 '25: 54.8M Q2 '25: 53.7M Q3 '25: 52.5M Q1 '26: 51M Q2 '26: 51.3M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-16.00 -8.00 0.00 8.00 16.00 24.00 Q4 '15: 2.57 Q1 '16: 2.44 Q2 '16: 2.30 Q3 '16: 2.29 Q4 '16: 0.92 Q1 '17: 1.86 Q2 '17: -2.82 Q3 '17: -5.28 Q4 '17: -9.02 Q1 '18: -8.75 Q2 '18: -1.63 Q3 '18: 2.97 Q4 '18: 10.57 Q1 '19: 11.92 Q2 '19: 11.96 Q3 '19: 11.81 Q4 '19: 11.47 Q1 '20: 11.40 Q2 '20: 12.99 Q3 '20: 13.34 Q4 '20: 11.25 Q1 '21: 12.22 Q2 '21: 10.73 Q3 '21: 10.09 Q4 '21: 11.25 Q1 '22: 11.75 Q2 '22: 12.84 Q3 '22: 14.33 Q4 '22: 13.56 Q1 '23: 14.69 Q2 '23: 15.79 Q3 '23: 16.05 Q4 '23: 18.77 Q1 '24: 18.42 Q2 '24: 18.24 Q3 '24: 19.68 Q4 '24: 20.44 Q1 '25: 20.72 Q2 '25: 20.30 Q3 '25: 16.16 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.